The 2nd International Congress on Adult Consequences of Childhood Endocrine Diseases

Session 1: The adipose tissue as an endocrine organ
Moderator: To be confirmed

The adipose cell-difference between peripheral and visceral fat
Speaker to be announced
Adiponectin
Speaker to be announced
Leptin and the GH neuroendocrine axis
Speaker to be announced
Ghrelin: from a GH- secretagogue to the regulation of food intake, sleep and anxiety
F. CASANUEVA (SP)
Insulin and human obesity
E. KOULOURIDIS (GR)

Friday morning, 7 May 2004
Session 2: Clinical aspects of obesity
Moderator: G.E. KRASSAS (GR)

Increasing incidence of childhood obesity
ZVI LARON (IS)
Do obese children become obese adults?
G.E. KRASSAS (GR)
The link between obesity and type 2 diabetes
CH. BARTSOKAS (GR)
New therapeutic approach in obesity
L. VAN GAAL (B) (to be confirmed)

Friday afternoon, 7 May 2004
Session 3: New applications of GH therapy
Moderator: M.O. SAVAGE (UK)

Prader Willi Syndrome: long term results
Speaker to be announced
2nd topic: Effect of GH on the immune system
M. BOZZOLA (IT) (to be confirmed)
Long-term follow-up of GH treatment of children with IUGR
ATTANASIO (IT) (to be confirmed)
Continuation of GH treatment in adult life in children with GH deficiency
Speaker to be announced

GALA DINNER

Saturday morning, 8 May 2004

Session 4: New drugs affecting the GH/IGF-I axis and their possible clinical applications (GH antagonists)
Moderator: ZVI LARON (IS)

Acromegaly
Speaker to be announced
Nephropathy
A. FLYVBJERG (DM)
Ophthalmology (somatostatin analogues)
Speaker to be announced
GEP tumors
Speaker to be announced

Saturday afternoon, 8 May 2004

Session 5: Diabetes in children and adolescents
Moderator: To be announced

Genetics in type 1 DM
Speaker to be announced
Hypoglycemia in childhood. Long-term effects
Speaker to be announced
New insights into the pathogenesis of diabetic neuropathy
Speaker to be announced
Closing the Loop - Usefulness in insulin pump therapy and glucose sensors
MOSHE PHILLIP (IS)

Closing Remarks: